» Articles » PMID: 10027448

Inadequate Antimicrobial Treatment of Infections: a Risk Factor for Hospital Mortality Among Critically Ill Patients

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 1999 Feb 23
PMID 10027448
Citations 420
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: To evaluate the relationship between inadequate antimicrobial treatment of infections (both community-acquired and nosocomial infections) and hospital mortality for patients requiring ICU admission.

Design: Prospective cohort study.

Setting: Barnes-Jewish Hospital, a university-affiliated urban teaching hospital.

Patients: Two thousand consecutive patients requiring admission to the medical or surgical ICU.

Interventions: Prospective patient surveillance and data collection.

Measurements And Results: One hundred sixty-nine (8.5%) infected patients received inadequate antimicrobial treatment of their infections. This represented 25.8% of the 655 patients assessed to have either community-acquired or nosocomial infections. The occurrence of inadequate antimicrobial treatment of infection was most common among patients with nosocomial infections, which developed after treatment of a community-acquired infection (45.2%), followed by patients with nosocomial infections alone (34.3%) and patients with community-acquired infections alone (17.1%) (p < 0.001). Multiple logistic regression analysis, using only the cohort of infected patients (n = 655), demonstrated that the prior administration of antibiotics (adjusted odds ratio [OR], 3.39; 95% confidence interval [CI], 2.88 to 4.23; p < 0.001), presence of a bloodstream infection (adjusted OR, 1.88; 95% CI, 1.52 to 2.32; p = 0.003), increasing acute physiology and chronic health evaluation (APACHE) II scores (adjusted OR, 1.04; 95% CI, 1.03 to 1.05; p = 0.002), and decreasing patient age (adjusted OR, 1.01; 95% CI, 1.01 to 1.02; p = 0.012) were independently associated with the administration of inadequate antimicrobial treatment. The hospital mortality rate of infected patients receiving inadequate antimicrobial treatment (52.1%) was statistically greater than the hospital mortality rate of the remaining patients in the cohort (n = 1,831) without this risk factor (12.2%) (relative risk [RR], 4.26; 95% CI, 3.52 to 5.15; p < 0.001). Similarly, the infection-related mortality rate for infected patients receiving inadequate antimicrobial treatment (42.0%) was significantly greater than the infection-related mortality rate of infected patients receiving adequate antimicrobial treatment (17.7%) (RR, 2.37; 95% CI, 1.83 to 3.08; p < 0.001). Using a logistic regression model, inadequate antimicrobial treatment of infection was found to be the most important independent determinant of hospital mortality for the entire patient cohort (adjusted OR, 4.27; 95% CI, 3.35 to 5.44; p < 0.001). The other identified independent determinants of hospital mortality included the number of acquired organ system derangements, use of vasopressor agents, the presence of an underlying malignancy, increasing APACHE II scores, increasing age, and having a nonsurgical diagnosis at the time of ICU admission.

Conclusions: Inadequate treatment of infections among patients requiring ICU admission appears to be an important determinant of hospital mortality. These data suggest that clinical efforts aimed at reducing the occurrence of inadequate antimicrobial treatment could improve the outcomes of critically ill patients. Additionally, prior antimicrobial therapy should be recognized as an important risk factor for the administration of inadequate antimicrobial treatment among ICU patients with clinically suspected infections.

Citing Articles

Development of a Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide empiric antibiotic treatment for ventilator-associated pneumonia in a Mexican tertiary care university hospital.

Briseno-Ramirez J, Gomez-Quiroz A, Avila-Cardenas B, De Arcos-Jimenez J, Perales-Guerrero L, Andrade-Villanueva J BMC Infect Dis. 2025; 25(1):307.

PMID: 40038606 PMC: 11877913. DOI: 10.1186/s12879-025-10677-0.


The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.

Shime N, Nakada T, Yatabe T, Yamakawa K, Aoki Y, Inoue S Acute Med Surg. 2025; 12(1):e70037.

PMID: 39996161 PMC: 11848044. DOI: 10.1002/ams2.70037.


Diagnostic Performance and Impact on Antimicrobial Treatment of a Multiplex Polymerase Chain Reaction in Critically Ill Patients With Pneumonia: A Multicenter Observational Study (The MORICUP-PCR Study: Morocco ICU Pneumonia-PCR study).

Aissaoui Y, Derkaoui A, Hachimi A, Bouchama A, Dendane T, Doumiri M Crit Care Explor. 2025; 7(2):e1220.

PMID: 39937572 PMC: 11826045. DOI: 10.1097/CCE.0000000000001220.


Modeling and simulation of distribution and drug resistance of major pathogens in patients with respiratory system infections.

Yang L, Liang E, Gao Y BMC Infect Dis. 2025; 25(1):138.

PMID: 39881259 PMC: 11780821. DOI: 10.1186/s12879-025-10549-7.


Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial.

Banerjee R, Giri A, Komarow L, Souli M, Doernberg S, Patel R Microbiol Spectr. 2024; 13(2):e0178924.

PMID: 39679788 PMC: 11792449. DOI: 10.1128/spectrum.01789-24.